Trial Profile
A Study to Evaluate Whether the Efficacy and Safety of Maraviroc Addition to Stable Antiretroviral Regimen in HIV Patients is Independent of The Patient's Age at Treatment Onset
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jul 2016
Price :
$35
*
At a glance
- Drugs Maraviroc (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- 14 Jul 2016 New trial record